Is GT Biopharma, Inc. (GTBP) a Buy, Sell, or Hold?
NASDAQ : GTBP
GT Biopharma, Inc. — Competitors
$0.3201 USD
$0.02 (6.35%)
- Volume
- 568.21K
- Average Volume
- 1.49M
- Market Capitalization
- $10.1M
- P/E Ratio
- -0.05
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $1.78
- Year Low
- $0.26
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $3.69
GTBP vs. The Competition
| Properties | GTBP | ARTL | CARM | DRMA |
|---|---|---|---|---|
| Market Cap | $10.1M | $2.51M | $104.61K | $749.71K |
| Shares Outstanding | $31.55M | $3.49M | $41.85M | $681.56K |
| P/E Ratio | -0.05 | -0.08 | 0.0 | -0.21 |
| EPS | -1.58 | -18.22 | 0.61 | -1.84 |
| Day Low | 0.301 | 0.721 | 0.0025 | 1.09 |
| Day High | 0.3275 | 0.721 | 0.0324 | 1.18 |
| Year Low | 0.261 | 0.705 | 0.0001 | 0.951 |
| Year High | 1.78 | 31.65 | 0.556 | 6.575 |
| Average Price 50 | 0.4073 | 1.12462 | 0.006279 | 1.2558 |
| Average Price 200 | 0.51817 | 4.01806 | 0.02736975 | 1.80424 |
| Volume | 568.21K | 114.95K | 10296 | 72044 |
| Average Volume | - | - | - | - |